Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling
Top Cited Papers
Open Access
- 18 October 2002
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 70 (3), 462-473
- https://doi.org/10.1002/jnr.10351
Abstract
Alterations in transcription, RNA editing, translation, protein processing, and clearance are a consistent feature of Alzheimer's disease (AD) brain. To extend our initial study (Alzheimer Reports [2000] 3:161-167), RNA samples isolated from control and AD hippocampal cornu ammonis 1 (CA1) were analyzed for 12633 gene and expressed sequence tag (EST) expression levels using DNA microarrays (HG-U95Av2 Genechips; Affymetrix, Santa Clara, CA). Hippocampal CA1 tissues were carefully selected from several hundred potential specimens obtained from domestic and international brain banks. To minimize the effects of individual differences in gene expression, RNA of high spectral quality (A260/280 ≥ 1.9) was pooled from CA1 of six control or six AD subjects. Results were compared as a group; individual gene expression patterns for the most-changed RNA message levels were also profiled. There were no significant differences in age, postmortem interval (mean ≤ 2.1 hr) nor tissue pH (range 6.6–6.9) between the two brain groups. AD tissues were derived from subjects clinically classified as CDR 2-3 (CERAD/NIA). Expression data were analyzed using GeneSpring (Silicon Genetics, Redwood City, CA) and Microarray Data Mining Tool (Affymetrix) software. Compared to controls and 354 background/alignment markers, AD brain showed a generalized depression in brain gene transcription, including decreases in RNA encoding transcription factors (TFs), neurotrophic factors, signaling elements involved in synaptic plasticity such as synaptophysin, metallothionein III, and metal regulatory factor-1. Three- or morefold increases in RNAs encoding DAXX, cPLA2, CDP5, NF-κBp52/p100, FAS, βAPP, DPP1, NFIL6, IL precursor, B94, HB15, COX-2, and CEX-1 signals were strikingly apparent. These data support the hypothesis of widespread transcriptional alterations, misregulation of RNAs involved in metal ion homeostasis, TF signaling deficits, decreases in neurotrophic support and activated apoptotic and neuroinflammatory signaling in moderately affected AD hippocampal CA1.Keywords
This publication has 68 references indexed in Scilit:
- Stabilization of Vascular Endothelial Growth Factor mRNA by Hypoxia-Inducible Factor 1Biochemical and Biophysical Research Communications, 2002
- Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptideTrends in Molecular Medicine, 2001
- Molecular and cell biological aspects of Alzheimer diseaseJournal of Human Genetics, 2001
- HuR and mRNA stabilityCellular and Molecular Life Sciences, 2001
- Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's diseaseJournal of Neuroscience Research, 1999
- The Cell Death-promoting Gene DP5, Which Interacts with the BCL2 Family, Is Induced during Neuronal Apoptosis Following Exposure to Amyloid β ProteinPublished by Elsevier ,1999
- Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease BrainsBiochemical and Biophysical Research Communications, 1999
- ALZHEIMER'S DISEASE: Genetic Studies and Transgenic ModelsAnnual Review of Genetics, 1998
- Molecular mechanisms that underlie structural and functional changes atthe postsynaptic membrane duringsynaptic plasticityProgress in Neurobiology, 1998
- Frameshift Mutants of β Amyloid Precursor Protein and Ubiquitin-B in Alzheimer's and Down PatientsScience, 1998